| 2026-08-14 | Press release | Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update |
| 2026-08-07 | Press release | Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET |
| 2026-08-03 | Press release | Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-A |
| 2026-07-28 | Press release | Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Ca |
| 2026-07-13 | Presentation | Download PDF file, (opens in new window) |
| 2026-06-02 | Press release | Download , Lantern Pharma Reports HARMONIC™ Data Showing LP-300 Progression-Free Survival Benefit Deepens with Treatment |
| 2026-05-19 | Press release | Download , Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-3 |
| 2026-05-19 | Press release | Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never |
| 2026-05-15 | Press release | Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026 |
| 2026-05-15 | Press release | Earnings Release
of Q1 2026, PDF file, (opens in new window) |
| 2026-05-11 | Press release | Download , Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026, May 11, 2026, (o |
| 2026-05-01 | Presentation | Download PDF (opens in new window) |
| 2026-04-09 | Press release | Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Live Demo of |
| 2026-04-02 | Press release | Download , Lantern Pharma Invites Investors, Analysts & Shareholders to Experience the Future of Drug Discovery via a Li |
| 2026-03-30 | Earnings deck | Presentation Open Event Link, PDF file, March 30, 2026, (opens in new window) |
| 2026-03-30 | Press release | Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p |
| 2026-03-30 | Press release | Download , Lantern Pharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates, Mar |
| 2026-03-30 | Press release | Earnings Release of Q4 2025 Press Release, (opens in new window) |
| 2026-03-27 | Press release | Download , Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third |
| 2026-03-23 | Press release | Download , Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 202 |
| 2026-02-17 | Press release | Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026 |
| 2026-02-10 | Press release | Download , Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026, |
| 2026-01-20 | Press release | Download , Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas, January 20, 2026, (ope |
| 2025-03-27 | Press release | Earnings Release |
| 2025-03-27 | Press release | Q4 |
| 2025-03-27 | Earnings deck | Q4 |
| 2024-11-07 | Press release | Earnings Release |
| 2024-11-07 | Earnings deck | Q3 |
| 2024-11-07 | Press release | Q3 |
| 2024-08-08 | Earnings deck | Q2 |
| 2024-08-08 | Press release | Q2 |
| 2024-05-09 | Press release | Earnings Release |
| 2024-05-09 | Press release | Earnings Release |
| 2024-05-09 | Presentation | Q1 |
| 2024-03-18 | Press release | Earnings Release |
| 2024-03-18 | Press release | Earnings Release |
| 2024-03-18 | Earnings deck | Q4 |
| 2023-11-08 | Press release | Earnings Release |
| 2023-11-08 | Presentation | Q3 |
| 2023-08-09 | Press release | Earnings Release |